162 related articles for article (PubMed ID: 16536004)
1. [Pharmacologic treatment of sarcoidosis].
Cîlţ C
Pneumologia; 2005; 54(2):66-71. PubMed ID: 16536004
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous sarcoidosis therapy updated.
Badgwell C; Rosen T
J Am Acad Dermatol; 2007 Jan; 56(1):69-83. PubMed ID: 17190623
[TBL] [Abstract][Full Text] [Related]
3. Targeting the TNF-alpha pathway in sarcoidosis.
Antoniu SA
Expert Opin Ther Targets; 2010 Jan; 14(1):21-9. PubMed ID: 20001207
[TBL] [Abstract][Full Text] [Related]
4. [Sarcoidosis: changing insights in therapy].
Kamphuis LS; van Laar JA; Kuijpers RW; Missotten T; Thio HB; van Hagen PM
Ned Tijdschr Geneeskd; 2010; 154(47):A1685. PubMed ID: 21118599
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha-targeted therapy in rheumatoid arthritis.
Wendling D; Toussirot E
Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
[No Abstract] [Full Text] [Related]
6. Refractory vertebral sarcoidosis responding to infliximab.
Garg S; Garg K; Altaf M; Magaldi JA
J Clin Rheumatol; 2008 Aug; 14(4):238-40. PubMed ID: 18766126
[TBL] [Abstract][Full Text] [Related]
7. Disseminated cryptococcal infection and anti-tumor necrosis factor-alpha treatment for refractory sarcoidosis: an expected association?
Arnaud L; Sene D; Costedoat-Chalumeau N; Cacoub P; Chapelon-Abric C; Piette JC
J Rheumatol; 2009 Feb; 36(2):462-3. PubMed ID: 19208587
[No Abstract] [Full Text] [Related]
8. [The role of tumor necrosis factor in pathogenesis and treatment of sarcoidosis].
Vizel' AA; Guryleva ME; Vizel' EA; Nasretdinova GP
Klin Med (Mosk); 2003; 81(9):4-8. PubMed ID: 14598582
[No Abstract] [Full Text] [Related]
9. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.
Sweiss NJ; Welsch MJ; Curran JJ; Ellman MH
Arthritis Rheum; 2005 Oct; 53(5):788-91. PubMed ID: 16208666
[No Abstract] [Full Text] [Related]
10. Treatment of sarcoidosis.
King CS; Kelly W
Dis Mon; 2009 Nov; 55(11):704-18. PubMed ID: 19857644
[No Abstract] [Full Text] [Related]
11. TNF--a antagonists and sarcoidosis.
Culver DA; Baughman RP
QJM; 2011 Apr; 104(4):374. PubMed ID: 21278060
[No Abstract] [Full Text] [Related]
12. [Successful treatment with infliximab of a patient with refractory sarcoidosis].
Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311
[TBL] [Abstract][Full Text] [Related]
13. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists.
Thielen AM; Barde C; Saurat JH; Laffitte E
Dermatology; 2009; 219(1):59-62. PubMed ID: 19468200
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF therapeutics for the treatment of sarcoidosis.
Crommelin HA; Vorselaars AD; van Moorsel CH; Korenromp IH; Deneer VH; Grutters JC
Immunotherapy; 2014; 6(10):1127-43. PubMed ID: 25428650
[TBL] [Abstract][Full Text] [Related]
15. [Misdiagnosed childhood sarcoidosis as non-Langerhans' cell histiocytosis treated with tumor necrosis factors-α antagonists].
Petiti Martin G; Castellanos González M; Sanz Bueno J; Burgués Calderón M; Villar Buil M; Vanaclocha F; Peralto JL
An Pediatr (Barc); 2012 Oct; 77(4):267-71. PubMed ID: 22608978
[TBL] [Abstract][Full Text] [Related]
16. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis.
Baughman RP; Strohofer SA; Buchsbaum J; Lower EE
J Lab Clin Med; 1990 Jan; 115(1):36-42. PubMed ID: 2299255
[TBL] [Abstract][Full Text] [Related]
17. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.
Sweiss NJ; Curran J; Baughman RP
Clin Dermatol; 2007; 25(3):341-6. PubMed ID: 17560312
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha blockade as therapy for sarcoidosis: comment on the article by Ulbricht et al.
Lee AS; Utz JP; Specks U
Arthritis Rheum; 2004 Aug; 50(8):2717-8; author reply 2718-9. PubMed ID: 15334498
[No Abstract] [Full Text] [Related]
19. [Refractory neurosarcoidosis and infliximab: a growing experience].
Ritzenthaler T; Gonzalez-Martinez V; Guegen A; Tilikete C; Vighetto A
Rev Neurol (Paris); 2009 Feb; 165(2):197-200. PubMed ID: 18653204
[TBL] [Abstract][Full Text] [Related]
20. Treatment of sarcoidosis -- from a basic science point of view.
Moller DR
J Intern Med; 2003 Jan; 253(1):31-40. PubMed ID: 12588536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
